Adagio Medical Holdings, Inc. (ADGM)
NASDAQ: ADGM · Real-Time Price · USD
1.000
-0.060 (-5.66%)
Dec 27, 2024, 10:14 AM EST - Market open
Adagio Medical Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Revenue | 0.54 | 0.3 | 0.19 |
| Revenue Growth (YoY) | 187.30% | 58.73% | - |
| Cost of Revenue | 2.13 | 1.31 | 0.88 |
| Gross Profit | -1.59 | -1.01 | -0.69 |
| Selling, General & Admin | 19.28 | 11.54 | 5.37 |
| Research & Development | 10.58 | 15.4 | 17.86 |
| Operating Expenses | 29.85 | 26.94 | 23.23 |
| Operating Income | -31.44 | -27.94 | -23.91 |
| Interest Expense | -2.83 | -1.66 | -0.14 |
| Interest & Investment Income | 0.17 | 0 | 0.04 |
| Other Non Operating Income (Expenses) | 7.81 | -6.99 | 0.34 |
| Pretax Income | -26.29 | -36.59 | -23.67 |
| Net Income | -26.29 | -36.59 | -23.67 |
| Net Income to Common | -7.54 | -36.59 | -23.67 |
| Shares Outstanding (Basic) | 3 | 1 | 1 |
| Shares Outstanding (Diluted) | 3 | 1 | 1 |
| Shares Change (YoY) | 305.73% | 1.10% | - |
| EPS (Basic) | -2.47 | -48.16 | -31.50 |
| EPS (Diluted) | -2.47 | -48.16 | -31.50 |
| Free Cash Flow | -30.41 | -25.99 | -22.9 |
| Free Cash Flow Per Share | -9.97 | -34.20 | -30.47 |
| Operating Margin | -5789.69% | -9314.00% | -12652.38% |
| Profit Margin | -1388.03% | -12196.67% | -12525.40% |
| Free Cash Flow Margin | -5599.45% | -8661.67% | -12118.52% |
| EBITDA | -30.34 | -27.41 | -23.42 |
| D&A For EBITDA | 1.1 | 0.53 | 0.5 |
| EBIT | -31.44 | -27.94 | -23.91 |
Source: S&P Capital IQ. Standard template.
Financial Sources.